Medical Disorders
Resources
Basic InformationLookupsLatest News
Obesity More Deadly for Men Than Women When COVID StrikesReal-World Studies Show Pfizer Vaccine Shields Against COVID Variants1 in 4 U.S. Teens Has Had a Concussion: StudyWhat's the Right Amount of Sleep for a Healthy Heart?U.S. COVID Outlook Shows Big Improvement by July'Prediabetes' Raises Odds for Heart Attack, StrokeA Vitamin Could Be Key to Women's Pain After Knee ReplacementBiden Sets New Goal of Vaccinating 70% of Americans by July 4Wildfires Are Changing the Seasonal Air Quality of the U.S. WestMany Americans Wrong About Sun's Skin Cancer Dangers: PollNot Just About Antibodies: Why mRNA COVID Vaccines May Shield From VariantsYou Got Your COVID Shot: What to Do With That Vaccine CardFDA Plans to OK Pfizer Vaccine for Those Aged 12 and UpAHA News: As Pre-Pandemic Activities Return, So Does AnxietyCOVID Anxieties Still High for Americans: PollCOVID Vaccination in Pregnancy May Pass Helpful Antibodies to BabyWhy U.S. Hispanics Got COVID at Higher Rates: Their JobsHerd Immunity for Americans May Be an Elusive Goal, Experts SayUrgent Care or the ER? Which Should You Choose?Needle Anxiety Behind J&J COVID Vaccine Reaction Clusters: Study1 in 5 Patients on Kidney Dialysis Say No to COVID-19 Vaccine: StudyYoung, Immune-Compromised Patients Are Hotspots for Coronavirus Mutations: StudyCOVID Deaths Continue to Decline in U.S.Researchers Seek Antiviral Pill That Would Ease COVID SeverityAHA News: Take Stock of Your Health With This Post-Lockdown ChecklistPoll Reveals Who's Most Vaccine-Hesitant in America and WhyGood Stroke Recovery May Depend on Your ZIP Code: StudyNew Advice for Blood Pressure That's a Bit Too HighMany U.S. Colleges Will Mandate Vaccines on Campus Next Fall: SurveyPfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at SecondAbout 1 in 7 Who Get Pfizer Vaccine Will Have Any 'Systemic' Side Effect: StudyPolls Find Most U.S. Young People Take COVID Threat SeriouslyAHA News: Experts Remain Confident About Vaccine Safety MonitoringNothing to Sniff at: Depression Common for People With COVID-Linked Smell LossHead Injury, Alzheimer's Appear to Affect Brain in Similar WaysCDC Says Vaccinated Can Shed Masks Outside, Except in CrowdsCOVID-19 Could Raise Odds for Heart Failure, Even in Those With No Prior Heart RiskU.S. to Share Up to 60 Million Doses of AstraZeneca Vaccine With Other CountriesLow Risk of Mom Passing COVID to NewbornThese Factors Could Lead to a Real Pain in the NeckWhy COVID Infection Raises Risks in PregnancyNew Drug May Be Better Psoriasis TreatmentMillions of Americans Have Missed Their Second COVID Vaccine Dose: CDCIs a Cheap 'Universal' Coronavirus Vaccine on the Way?Vertigo: A Common Symptom With Many Different CausesFDA Moves to Resume Use of J&J COVID Vaccine'Garage Lab' Vape Products May Be Driving Lung Injury in Rural AppalachiaNBA Study Shows Post-COVID Viral Transmission Rare, Even With Positive TestCDC Decision on Johnson & Johnson Vaccine Pause Expected FridayAHA News: How to Make Sure Everyone Gets a Fair Shot at the COVID-19 Vaccine
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Poll Reveals Who's Most Vaccine-Hesitant in America and Why

HealthDay News
by Cara Murez
Updated: Apr 29th 2021

new article illustration

THURSDAY, April 29, 2021 (HealthDay News) -- U.S. resistance to getting a COVID-19 vaccine is slowly diminishing, a new online survey finds, but it still exists and at especially high rates in some blue-collar jobs.

For adults under age 65 who are hesitant, reluctance is mainly driven by concerns about safety, side effects and distrust in government, the poll found. It's also largely linked to people's line of work.

The bottom line: "Vaccine hesitancy is emerging as a key barrier to ending the COVID-19 pandemic," said lead author Wendy King, associate professor of epidemiology in the University of Pittsburgh Graduate School of Public Health.

Identifying occupations with a high rate of vaccine hesitancy and understanding the reasons for it might help public health workers address concerns, she said.

"Our study indicates that messaging about COVID-19 vaccine safety and addressing trust are paramount," King said in a university news release.

King and researchers from the Delphi Group at nearby Carnegie Mellon University analyzed results from its ongoing COVID-19 survey in collaboration with the Facebook Data for Good group. About 1.2 million U.S. residents in Facebook's active user database complete the survey each month.

In January, the survey added a question about willingness to receive the vaccine.

This study was limited to working-age adults, because workplace outbreaks and spread of infection from workers to customers are public health threats. Many working-age adults also are more hesitant about getting a shot than older Americans.

While resistance persists, there was some encouraging news: Vaccine hesitancy fell from 27.5% in January to 22% in March, according to the survey.

The March survey included 732,308 people (median age: 35 to 44, meaning half were older, half younger). About 45% were male, 77% had some college education and 64% were white.

Nearly 48% of those who reported vaccine hesitancy expressed concern about side effects. More than one-third didn't think they needed the shot, didn't trust the government, were waiting to see if the vaccine was safe or didn't trust COVID-19 vaccines specifically. And 14.5% said they didn't like vaccines in general.

Workers in some occupations were more reluctant than others to take the jab. Hesitancy ranged from 9.6% among educators and people in life, physical or social sciences to a high of 46% among workers in construction, oil and gas extraction and mining. Hesitancy was nearly as high among workers in installation, maintenance, repair, farming, fishing or forestry.

In health care fields, pharmacists were the least hesitant at 8.5%. The highest hesitancy, 20.5%, was among medical assistants, emergency medical technicians and home health, nursing, psychiatric or personal-care aides.

"The survey has grown to collect data on symptoms, illness, treatment, testing, behaviors like masking and distancing, and mental health," said senior author Robin Mejia, from Carnegie Mellon's Dietrich College of Humanities and Social Sciences. "And it's continuing to evolve as new policy questions arise."

The survey results were posted April 24 on the preprint server medRxiv and have not been peer-reviewed.

More information

The U.S. Centers for Disease Control and Prevention has more information on COVID-19 and vaccinations.

SOURCE: University of Pittsburgh, news release, April 28, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net